Thomson Reuters: One-Stop IP Management

May 2013
Information Today;May2013, Vol. 30 Issue 5, p13
Trade Publication
The article profiles the international business enterprise Thomson Reuters and discusses several products and services which are available from the company, including the Derwent World Patents Index, the Thomson IP Manager and IP Payments from Thomson Reuters. A business relationship which was established between Thomson Reuters and the agricultural company Syngenta is discussed.


Related Articles

  • Wolters Kluwer. SCARDILLI, BRANDI // Information Today;Jul/Aug2016, Vol. 33 Issue 6, p23 

    The article offers brief information on updated version of Corsearch solution called the Corsearch FOCUS for protecting brands and trademarks from Wolters Kluwer NV.

  • The production of generic drugs in India: Would be affected by new trade agreement with EU. Love, James // BMJ: British Medical Journal (International Edition);4/2/2011, Vol. 342 Issue 7800, p721 

    The author reflects on the trade agreement negotiated between European Union (EU) and India which may affect the production of generic drugs. The author says that the deal, which restricts ownership and enforcement of intellectual property for medical inventions, if implemented, may shrink the...

  • Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity. Morag-Sela, Tamar; Cohn, Ilan; Kowalski, Thomas J.; Jarecki-Black, Judy; Clyde-Watson, Zoe // Nature Biotechnology;Dec2004, Vol. 22 Issue 12, p1591 

    The article discusses issues related to intellectual property (IP) rights to pharmaceuticals in Israel. The country has a very strong generic pharmaceutical industry. Israel's past record of defending and respecting IP rights has led major companies around the world to file patent applications...

  • Thomson Reuters: 'One World, One Source' BRYNKO, BARBARA // Information Today;Jul/Aug2012, Vol. 29 Issue 7, p31 

    The article evaluates the Saegis on Serion platform solution trademark content database by Thomson CompuMark, a business of Thomson Reuters Intellectual Property and Science.

  • EMPRESAS MULTINACIONAIS DE ORIGEM BRASILEIRA E A PUBLICAÇÃO INTERNACIONAL DE PATENTES. Moura, Paulo; Ribeiro Galina, Simone Vasconcelos // Revista de Administração e Inovação - RAI;set-dez2009, Vol. 6 Issue 3, p26 

    Patents are documents of public domain used to obtain intellectual property protection for technical inventions. Such protection is limited by the geographical area and time, which means that every patent has a fixed period of protection and a region of coverage. In exchange for giving this...

  • Presidential Messaging, Innovation, and Intellectual Property. DAMES, K. MATTHEW // Information Today;Apr2011, Vol. 28 Issue 4, p24 

    The article examines U.S. President Barack Obama's 2011 State of the Union address on January 25, 2011, stressing the role of American innovation and creativity to U.S. economy and the necessity of protecting its intellectual property (IP). It mentions organizations like the General Agreement on...

  • International patent systems strength 1998–2011. Papageorgiadis, Nikolaos; Cross, Adam R.; Alexiou, Constantinos // Journal of World Business;Oct2014, Vol. 49 Issue 4, p586 

    In this paper we report on a composite index of international patent systems strength for 48 developing and industrialized countries annually from 1998 to 2011. Building upon earlier indices we develop a conceptual framework informed by transaction cost theory and derive measures which emphasize...

  • A "Calibrated Approach": Pharmaceutical FDI and the Evolution of Indian Patent Law. Linton, Katherine Connor; Corrado, Nicholas // Journal of International Commerce & Economics;Aug2008, Vol. I, p163 

    India has charted its own intellectual property (IP) path over the last 35 years, attempting to foster the growth of a domestic pharmaceutical industry and access to medicine while, more recently, also addressing the requirements of the international IP regime. Multinational companies (MNCs)...

  • The High Price of 'Free' Trade: U.S. Trade Agreements and Access to Medicines. Lopert, Ruth; Gleeson, Deborah // Journal of Law, Medicine & Ethics;Spring2013, Vol. 41 Issue 1, p199 

    The United States' pursuit of increasingly TRIPS-Plus levels of intellectual property protection for medicines in bilateral and regional trade agreements is well recognized. Less so, however, are U.S. efforts through these agreements to influence and constrain the pharmaceutical coverage...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics